Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Atypical Hyperplasia”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Early research (Phase 1)Study completedNCT03323658
What this trial is testing

Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Ductal Carcinoma In Situ+2 more
National Cancer Institute (NCI) 24
Not applicableUnknownNCT05717634
What this trial is testing

Endometrial Changes in Breast Cancer Women.

Who this might be right for
Endometrial CancerEndometrial Hyperplasia With AtypiaBreast Cancer+1 more
Regina Elena Cancer Institute 829
Large-scale testing (Phase 3)Active Not RecruitingNCT01905046
What this trial is testing

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+2 more
Alliance for Clinical Trials in Oncology 86
Not applicableStudy completedNCT00627276
What this trial is testing

Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

Who this might be right for
Breast CancerPrecancerous Condition
OHSU Knight Cancer Institute 16
Not applicableStudy completedNCT00291122
What this trial is testing

An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas 100
Not applicableStudy completedNCT00146536
What this trial is testing

Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent Excisional Biopsy

Who this might be right for
Breast Neoplasms
Dana-Farber Cancer Institute 78
Not applicableStudy completedNCT00620087
What this trial is testing

Molecular Breast Imaging in Women With Atypia and LCIS

Who this might be right for
Atypical Lobular HyperplasiaAtypical Ductal HyperplasiaLobular Carcinoma in Situ
Mayo Clinic 66
Not applicableActive Not RecruitingNCT04496739
What this trial is testing

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Who this might be right for
Atypical Hyperplasia of the BreastLobular Breast Carcinoma In SituPleomorphic Lobular Breast Carcinoma In Situ
SWOG Cancer Research Network 412
Not applicableStudy completedNCT01874184
What this trial is testing

Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer

Who this might be right for
Atypical Ductal Breast HyperplasiaAtypical Lobular Breast HyperplasiaBRCA1 Mutation Carrier+3 more
University of Washington 17
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Not applicableLooking for participantsNCT05178498
What this trial is testing

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+2 more
Ohio State University Comprehensive Cancer Center 960
Not applicableStudy completedNCT00291109
What this trial is testing

An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg

Who this might be right for
Breast Cancer
University of Kansas 40
Not applicableLooking for participantsNCT00291096
What this trial is testing

High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 3,000
Not applicableWithdrawnNCT00329017
What this trial is testing

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD
Not applicableStudy completedNCT00339248
What this trial is testing

Markers for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 2,632
Not applicableWithdrawnNCT03868475
What this trial is testing

Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions

Who this might be right for
Breast FibroadenomaAtypical Ductal HyperplasiaAtypical Lobular Hyperplasia+7 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Testing effectiveness (Phase 2)Looking for participantsNCT06195306
What this trial is testing

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Who this might be right for
Breast Atypical HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In Situ+1 more
National Cancer Institute (NCI) 66
Not applicableStudy completedNCT01925586
What this trial is testing

Atypical Lesions of the Breast: Close Observation Versus Excision (ALCOVE)

Who this might be right for
Atypical Ductal Hyperplasia (ADH) of the Breast
Yale University 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499999
What this trial is testing

Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerDuctal CarcinomaEstrogen-receptor-positive Breast Cancer+4 more
Dana-Farber Cancer Institute 140
Not applicableStudy completedNCT01052740
What this trial is testing

X-Ray Mammography Standard of Care Protocol

Who this might be right for
Breast CancerInvasive CarcinomaIn Situ Carcinoma+2 more
National Institutes of Health Clinical Center (CC) 108
Load More Results